High human renin hypertension in transgenic rats

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 428-434

  Bohlender, Jürgen ^e   Fukamizu, Akiyoshi ^c   Lippoldt, Andrea ^e   Nomura, Tatsuji ^a   Dietz, Rainer ^e   Ménard, Joel ^b   Murakami, Kazuo ^c   Luft, Friedrich C ^d   Ganten, Detlev ^e  

^a Ctrl Inst for Laboratory Animals   (Japan)

^b INSERM   (France)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d FRANZ VOLHARD CLINIC   (Germany)

^e NONE

Author keywords

angiotensin; hypertension, experimental; hypertrophy; nephrosclerosis; rats, transgenic; renin

Indexed keywords

REMIKIREN; RENIN; RENIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART HYPERTROPHY; HYPERTENSION; MALE; NEPHROSCLEROSIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL;

EID: 85026154669     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.428     Document Type: Article

References (25)

1. Bohlender J, Ménard J, Wagner J, Luft FC, Ganten D. Human renin-dependent hypertension in rats transgenic for human angiotensinogen. Hypertension. 1996;27(part 2):535-540.
2. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, Zimmermann F, Ruf P, Hilgenfeldt U, Ganten U, Kaling M, Bachmann S, Fukamizu A, Mullins JJ, Murakami K. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA 1992; 89:7806-7810.
3. Müller DN, Hilgers KF, Bohlender J, Lippoldt A, Wagner J, Fischli W, Ganten D, Mann JFE, Luft FC. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen Hypertension. 1995;26:272-278.
4. Bohlender J, Ménard J, Luft FC, Ganten D. Dose effects of human renin in rats transgenic for human angiotensinogen. Hypertension. In press.
5. Fukamizu A, Seo M-S, Hatae T, Yokoyama M, Nomura T, Katsuki M, Murakami K. Tissue-specific expression of the human renin gene in transgenic mice. Biochem Biophys Res Commun. 1989;165: 826-832.
6. Fischli W, Clozel J-P, El Amrani K, Wostl W, Neidhard W, Stadler H, Branca Q. RO 42-5892 is a potent orally active renin inhibitor in primates. Hypertension. 1991;18:22-31.
7. Poulsen K, Jörgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab. 1974;39:816-825.
8. Genain C, Bouhnik J, Tewksbury D, Corvol P, Ménard J. Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-Angiotensin I angiotensinogen by direct radioimmunoassay. J Clin Endocrinol Metab. 1984;59:478-484.
9. Auffray C, Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980;107:303-314.
10. 1 receptor blockade on pressure natriuresis and diuresis in (mRen2)27 transgenic rats. Hypertension. 1995;26:471-479.
11. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo M-S, Takahashi S, Hatae T, Kajiwara M, Yagami K, Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993;268: 11617-11621.
12. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robiliard JE, Sigmund CD Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047-1055.
13. Burton J, Quinn T. The amino-acid residues on the C-terminal side of the cleavage site of angiotensinogen influence the species specificity of the reaction with renin. Biochim Biophys Acta 1988;122: 923-926.
14. Oliver WJ, Gross F. Unique specificity of mouse angiotensinogen to homologous renin. Proc Soc Exp Biol Med. 1966;122:923-926.
15. Hatae T, Takimoto E, Murakami K, Fukamizu A. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem. 1994;131:43-47.
16. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502.
17. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344: 541-544.
18. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, Yokota Y, Iwai M, Tanabe Y, Masu M, Hata J. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1990;87: 5153-5157.
19. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11:821-827.
20. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
21. Khairallah PA, Robertson AL, Davila D. Effects of angiotensin II on DNA, RNA, and protein synthesis. In: Genest J, Koiw E. eds. Hypertension. New York, NY: Springer-Verlag; 1992:212-220.
22. Susie D, Nunez E, Frohlich ED, Prakash O. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension. 1996;28:265-268.
23. Haller H, Park JK, Dragun D, Lippoldt A, Luft FC. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant. In press.
24. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JFE, Dämmrich J, Luft FC. Interstitial accumulation of extracellular matrix molecules early in the development of hypertensive renal injury. Hypertension. 1993;22:754-765.
25. Hamaguchi A, Kim S, Ohta K, Yagi K, Yukimura T, Miura K, Fukuda T, Iwao H. Transforming growth factor-β1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension. 1995;26:199-207.